Pediatric acute lymphoblastic leukemia—Conquering the CNS across the choroid plexus. (August 2018)

• Record Type: Journal Article
• Authors: März, Martin; Meyer, Svenja; Erb, Ulrike; Georgikou, Christina; Horstmann, Martin A.; Hetjens, Svetlana; Weiß, Christel; Fallier-Becker, Petra; Vandenhaute, Elodie; Ishikawa, Hiroshi; Schroten, Horst; Dürken, Matthias; Karremann, Michael
• Is Part Of: Leukemia research. Volume 71(2018)
• Page Start: 47
• Page End: 54
• Publication Date: 2018-08
• Subjects: Blood-cerebrospinal fluid barrier -- Chemokine receptors -- Choroid plexus -- CNS infiltration -- Pediatric acute lymphoblastic leukemia; Leukemia -- Periodicals; Leukemia -- Periodicals; Leucémie -- Périodiques; Leukemia; Periodicals; Electronic journals; Electronic journals; 616.9941905
• DOI: 10.1016/j.leukres.2018.07.001
• Languages: English
• ISSNs: 0145-2126

Abstract

Highlights: We present a human derived in vitro model of the blood-cerebrospinal fluid barrier to investigate CNS invasion in ALL. Lymphoblasts are able to actively transmigrate across the choroid plexus epithelium in vitro . CXCL12/CXCR4-signaling may play a permissive role in CNS invasion across the BCSFB. Abstract: Despite the high prevalence of central nervous system (CNS) involvement in relapsing pediatric acute lymphoblastic leukemia (ALL), our understanding of CNS invasion is still vague. As lymphoblasts have to overcome the physiological blood-CNS barriers to enter the CNS, we investigated the cellular interactions of lymphoblasts with the choroid plexus (CP) epithelium of the blood-cerebrospinal fluid barrier (BCSFB). Both a precurser B cell ALL (pB-ALL) cell line (SD-1) and a T cell ALL (T-ALL) cell line (P12-Ishikawa) were able to actively cross the CP epithelium in a human in vitro model. We could illustrate a transcellular and (supposedly) paracellular transmigration by 3-dimensional immunofluorescence microscopy as well as electron microscopy. Chemotactic stimulation with CXCL12 during this process led to a significantly increased transmigration and blocking CXCL12/CXCR4-signaling by the CXCR4-inhibitor AMD3100 inhibited this effect. However, CXCR4 expression in primary ALL samples did not correlate to CNS disease, indicating that CXCR4-driven CNS invasion across the BCSFB might be a general property of pediatric ALL. Notably, we present a unique in vitro BCSFB model suitable to study CNS invasion of lymphoblasts in a human setting, providing the opportunity to investigate experimental variables, which may determine CNS disease childhood ALL.